End-of-day quote
Warsaw S.E.
03:30:00 21/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.089
PLN
|
-.--%
|
|
-.--%
|
+11.25%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
6.567
|
0.9194
|
0.5734
|
6.881
|
7.816
|
14.68
|
Enterprise Value (EV)
1 |
6.935
|
1.356
|
0.6494
|
6.98
|
7.941
|
14.72
|
P/E ratio
|
-12.5
x
|
-5.72
x
|
-1.84
x
|
27.4
x
|
-71.3
x
|
-1.52
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
21.6
x
|
3.1
x
|
2.19
x
|
154
x
|
257
x
|
45.8
x
|
EV / Revenue
|
22.8
x
|
4.57
x
|
2.48
x
|
156
x
|
261
x
|
45.9
x
|
EV / EBITDA
|
2,339
x
|
-12.6
x
|
8.82
x
|
-106
x
|
-
|
-
|
EV / FCF
|
-605
x
|
-201
x
|
1.78
x
|
5.26
x
|
-4.28
x
|
-121
x
|
FCF Yield
|
-0.17%
|
-0.5%
|
56.2%
|
19%
|
-23.3%
|
-0.82%
|
Price to Book
|
-21.5
x
|
-1.97
x
|
-1.21
x
|
-31
x
|
3.57
x
|
7.64
x
|
Nbr of stocks (in thousands)
|
13,134
|
13,134
|
16,383
|
16,383
|
41,574
|
1,04,094
|
Reference price
2 |
0.5000
|
0.0700
|
0.0350
|
0.4200
|
0.1880
|
0.1410
|
Announcement Date
|
30/05/18
|
21/03/19
|
29/05/20
|
14/05/21
|
31/05/22
|
31/05/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
0.3047
|
0.2968
|
0.2615
|
0.0446
|
0.0304
|
0.3206
|
EBITDA
1 |
0.002965
|
-0.1075
|
0.0737
|
-0.0657
|
-
|
-
|
EBIT
1 |
-0.000467
|
-0.1101
|
0.0736
|
-0.0658
|
-0.1045
|
-0.0851
|
Operating Margin
|
-0.15%
|
-37.11%
|
28.13%
|
-147.33%
|
-343.19%
|
-26.54%
|
Earnings before Tax (EBT)
1 |
-0.5273
|
-0.1607
|
-0.3045
|
0.2507
|
-0.1096
|
-9.634
|
Net income
1 |
-0.5273
|
-0.1607
|
-0.3115
|
0.2507
|
-0.1096
|
-9.645
|
Net margin
|
-173.07%
|
-54.13%
|
-119.12%
|
561.54%
|
-359.95%
|
-3,008.89%
|
EPS
2 |
-0.0401
|
-0.0122
|
-0.0190
|
0.0153
|
-0.002635
|
-0.0927
|
Free Cash Flow
1 |
-0.0115
|
-0.006762
|
0.3649
|
1.327
|
-1.854
|
-0.1213
|
FCF margin
|
-3.76%
|
-2.28%
|
139.54%
|
2,972.58%
|
-6,090.42%
|
-37.83%
|
FCF Conversion (EBITDA)
|
-
|
-
|
495.43%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
529.36%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/05/18
|
21/03/19
|
29/05/20
|
14/05/21
|
31/05/22
|
31/05/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
0.37
|
0.44
|
0.08
|
0.1
|
0.13
|
0.05
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
124
x
|
-4.062
x
|
1.032
x
|
-1.509
x
|
-
|
-
|
Free Cash Flow
1 |
-0.01
|
-0.01
|
0.36
|
1.33
|
-1.85
|
-0.12
|
ROE (net income / shareholders' equity)
|
1,256%
|
41.6%
|
66.3%
|
-72.2%
|
-11.2%
|
-470%
|
ROA (Net income/ Total Assets)
|
-0.05%
|
-31.1%
|
54.3%
|
-4.75%
|
-3.14%
|
-2.3%
|
Assets
1 |
1,169
|
0.5173
|
-0.5741
|
-5.273
|
3.485
|
420.2
|
Book Value Per Share
2 |
-0.0200
|
-0.0400
|
-0.0300
|
-0.0100
|
0.0500
|
0.0200
|
Cash Flow per Share
2 |
0.0100
|
0
|
0
|
0
|
0
|
-
|
Capex
1 |
0.02
|
0.03
|
-
|
-
|
-
|
-
|
Capex / Sales
|
4.92%
|
10.11%
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/05/18
|
21/03/19
|
29/05/20
|
14/05/21
|
31/05/22
|
31/05/23
|
|
1st Jan change
|
Capi.
|
---|
| +11.25% | 23.51L | | +25.52% | 8.9TCr | | -24.52% | 7.48TCr | | +0.49% | 2.5TCr | | +4.31% | 1.79TCr | | -14.25% | 1.64TCr | | +2.97% | 1.58TCr | | +79.20% | 1.32TCr | | +70.11% | 1.31TCr | | +40.44% | 1.29TCr |
Other Healthcare Facilities & Services
|